New Sleep Apnea Pill Shows Promise in Clinical Trials

A once-daily pill for sleep apnea is advancing through FDA review after clinical trials showed it reduced breathing disruptions by 44 percent.

The experimental drug could offer hope to millions who struggle with CPAP machines, though doctors urge realistic expectations.